Page last updated: 2024-10-20

pyridoxal and Non-alcoholic Fatty Liver Disease

pyridoxal has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies

Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.

Research Excerpts

ExcerptRelevanceReference
"Gut microbiota dysbiosis is intimately associated with development of non-alcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)."1.91Characterization of gut microbiome composition in Iranian patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. ( Abdollahiyan, S; Asadzadeh Aghdaei, H; Farahanie, A; Gérard, P; Hatami, B; Keshavarz Azizi Raftar, S; Monnoye, M; Nabavi-Rad, A; Salarieh, N; Yadegar, A; Zali, MR, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abdollahiyan, S1
Nabavi-Rad, A1
Keshavarz Azizi Raftar, S1
Monnoye, M1
Salarieh, N1
Farahanie, A1
Asadzadeh Aghdaei, H1
Zali, MR1
Hatami, B1
Gérard, P1
Yadegar, A1

Other Studies

1 other study available for pyridoxal and Non-alcoholic Fatty Liver Disease

ArticleYear
Characterization of gut microbiome composition in Iranian patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Scientific reports, 2023, Nov-23, Volume: 13, Issue:1

    Topics: Cross-Sectional Studies; Dysbiosis; Gastrointestinal Microbiome; Humans; Iran; Liver; Non-alcoholic

2023